Multilocus microsatellite genotyping array for investigation of genetic epidemiology of Pneumocystis jirovecii

Journal of Clinical Microbiology

Volumn 52, Issue 5, 2014, Pages 1391-1399

  Parobek, Christian M ^a   Jiang, Linda Y ^b   Patel, Jaymin C ^c   Alvarez Martínez, Miriam J ^d   Miro, Jose M ^e   Worodria, William ^f   Andama, Alfred ^f   Fong, Serena ^g   Huang, Laurence ^g,h   Meshnick, Steven R ^c   Taylor, Steve M ^c,i   Juliano, Jonathan J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of North Carolina at Chapel Hill   (United States)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f MAKERERE UNIVERSITY   (Uganda)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Division of Pulmonary and Critical Care Medicine   (United States)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPTEROATE SYNTHASE; SULFONAMIDE; MICROSATELLITE DNA;

ALLELE; ANTIFUNGAL RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DHPS GENE; FUNGAL GENE; FUNGAL GENOME; FUNGAL STRAIN; FUNGUS ISOLATION; GENE MUTATION; GENETIC DISTANCE; GENETIC EPIDEMIOLOGY; GENOTYPING TECHNIQUE; HETEROZYGOSITY; HUMAN; MICROSATELLITE MARKER; MOLECULAR EPIDEMIOLOGY; MULTILOCUS MICROSATELLITE GENOTYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POPULATION GENETIC STRUCTURE; PRIORITY JOURNAL; RELIABILITY; SPAIN; UGANDA; UNITED STATES; VALIDATION PROCESS; GENE LOCUS; GENETICS; GENOTYPE; MICROBIOLOGY; MUTATION; PNEUMONIA, PNEUMOCYSTIS; PROCEDURES;

DIHYDROPTEROATE SYNTHASE; GENES, FUNGAL; GENETIC LOCI; GENOTYPE; HUMANS; MICROSATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MUTATION; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; SPAIN; UGANDA; UNITED STATES;

EID: 84899509776     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02531-13     Document Type: Article

References (90)

1. Hoover DR, Saah AJ, Bacellar H, Phair J, Detels R, Anderson R, Kaslow RA. 1993. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N. Engl. J. Med. 329:1922-1926.
2. Wolff AJ, O'Donnell AE. 2001. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 120:1888-1893. http://dx.doi.org/10.1378/chest.120.6.1888.
3. San-Andrés F-J, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, Costa J-R, del Palacio A. 2003. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. Clin. Infect. Dis. 36:1177-1185. http://dx.doi.org/10.1086/374358.
4. Jain MK, Skiest DJ, Cloud JW, Jain CL, Burns D, Berggren RE. 2003. Changesin mortality relatedtohuman immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin. Infect. Dis. 36:1030-1038. http://dx.doi.org/10.1086/368186.
5. Pulvirenti J, Herrera P, Venkataraman P, Ahmed N. 2003. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era. AIDS Patient Care STDs 17:261-265. http://dx.doi.org/10.1089/108729103322108139.
6. Mansharamani NG, Garland R, Delaney D, Koziel H. 2000. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 118:704-711. http://dx.doi.org/10.1378/chest.118.3.704.
7. Walzer PD, Evans H E R, Copas AJ, Edwards SG, Grant AD, Miller RF. 2008. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin. Infect. Dis. 46:625-633. http://dx.doi.org/10.1086/526778.
8. Fei MW, Kim EJ, Sant CA, Jarlsberg LG, Davis JL, Swartzman A, Huang L. 2009. Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 64:1070-1076. http://dx.doi.org/10.1136/thx.2009.117846.
9. Fisk DT, Meshnick S, Kazanjian PH. 2003. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36:70-78. http://dx.doi.org/10.1086/344951.
10. Armstrong W, Meshnick S, Kazanjian P. 2000. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. Microbes Infect. 2:61-67. http://dx.doi.org/10.1016/ S1286-4579 (00) 00284-7.
11. Huang L, Beard CB, Creasman J, Levy D, Duchin JS, Lee S, Pieniazek N, Carter JL, del Rio C, Rimland D, Navin TR. 2000. Sulfa or sulfone prophylaxis and geographic region predict mutations inthe Pneumocystis carinii dihydropteroate synthase gene. J. Infect. Dis. 182:1192-1198. http://dx.doi.org/10.1086/315824.
12. Taylor SM, Meshnick SR, Worodria W, Andama A, Cattamanchi A, Davis JL, Yoo SD, Byanyima P, Kaswabuli S, Goodman CD, Huang L, International HIV-associated Opportunistic Pneumonias Study. 2012. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda. PLoS One 7:e49991. http://dx.doi.org/10.1371/journal.pone.0049991.
13. Coyle PV, McCaughey C, Nager A, McKenna J, O'Neill H, Feeney SA, Fairley D, Watt A, Cox C, Curran T. 2012. Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immunecompromised patients may be becoming a significant problem. J. Med. Microbiol. 61:1009-1015. http://dx.doi.org/10.1099/jmm.0.043984-0.
14. Branten AJ, Beckers PJ, Tiggeler RG, Hoitsma AJ. 1995. Pneumocystis carinii pneumonia in renal transplant recipients. Nephrol. Dial. Transplant. 10:1194-1197.
15. Hennequin C, Page B, Roux P, Legendre C, Kreis H. 1995. Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit. Eur. J. Clin. Microbiol. 14:122-126. http://dx.doi.org/10.1007/BF02111870.
16. de Boer M G J, Bruijnesteijn van Coppenraet L E S, Gaasbeek A, Berger SP, Gelinck L B S, van Houwelingen HC, van den Broek P, Kuijper EJ, Kroon FP, Vandenbroucke JP. 2007. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source? Clin. Infect. Dis. 44:1143-1149. http://dx.doi.org/10.1086/513198.
17. Arichi N, Kishikawa H, Mitsui Y, Kato T, Nishimura K, Tachikawa R, Tomii K, Shiina H, Igawa M, Ichikawa Y. 2009. Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant. Proc. 41:170-172. http://dx.doi.org/10.1016/j.transproceed.2008.10.027.
18. Sassi M, Ripamonti C, Mueller NJ, Yazaki H, Kutty G, Ma L, Huber C, Gogineni E, Oka S, Goto N, Fehr T, Gianella S, Konrad R, Sing A, Kovacs JA. 2012. Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence. Clin. Infect. Dis. 54:1437-1444. http://dx.doi.org/10.1093/cid/cis217.
19. Tanaka M, Sakai R, Koike R, Komano Y, Nanki T, Sakai F, Sugiyama H, Matsushima H, Kojima T, Ohta S, Ishibe Y, Sawabe T, Ota Y, Ohishi K, Miyazato H, Nonomura Y, Saito K, Tanaka Y, Nagasawa H, Takeuchi T, Nakajima A, Ohtsubo H, Onishi M, Goto Y, Dobashi H, Miyasaka N, Harigai M. 2012. Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors. Mod. Rheumatol. 22:849-858. http://dx.doi.org/10.1007/s10165-012-0615-z.
20. Goto N, Oka S. 2011. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl. Infect. Dis. 13:551-558. http://dx.doi.org/10.1111/j. 1399-3062.2011.00691.x.
21. Huang L, Cattamanchi A, Davis JL, den Boon S, Kovacs J, Meshnick S, Miller RF, Walzer PD, Worodria W, Masur H, International HIV-associated Opportunistic Pneumonias (IHOP) Study Lung HIV Study. 2011. HIV-associated Pneumocystis pneumonia. Proc. Am. Thorac. Soc. 8:294-300. http://dx.doi.org/10. 1513/pats.201009-062WR.
22. Matos O, Esteves F. 2010. Pneumocystis jirovecii multilocus gene sequencing: findings and implications. Future Microbiol. 5:1257-1267. http://dx.doi.org/10.2217/fmb.10.75.
23. Wakefield AE. 1998. Genetic heterogeneity in Pneumocystis carinii: an introduction. FEMS Immunol. Med. Microbiol. 22:5-13. http://dx.doi.org/10.1111/ j.1574-695X.1998.tb01182.x.
24. de Boer M G J, de Fijter JW, Kroon FP. 2011. Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review. Med. Mycol. 49:673-680.
25. Hauser PM, Blanc DS, Bille J, Francioli P. 1998. Typing methods to approach Pneumocystis carinii genetic heterogeneity. FEMS Immunol. Med. Microbiol. 22:27-35. http://dx.doi.org/10.1111/j.1574-695X.1998.tb01184.x.
26. Keely SP, Cushion MT, Stringer JR. 2003. Diversity at the locus associated with transcription of a variable surface antigen of Pneumocystis carinii as an index of population structure and dynamics in infected rats. Infect. Immun. 71:47-60. http://dx.doi.org/10.1128/IAI.71.1.47-60.2003.
27. Esteves F, Gaspar J, de Sousa B, Antunes F, Mansinho K, Matos O. 2012. Pneumocystis jirovecii multilocus genotyping in pooled DNA samples: a new approach for clinical and epidemiological studies. Clin. Microbiol. Infect. 18:E177-E184. http://dx.doi.org/10.1111/j.1469-0691.2012.03828.x.
28. Esteves F, Gaspar J, De Sousa B, Antunes F, Mansinho K, Matos O. 2011. Clinical relevance of multiple single-nucleotide polymorphisms in Pneumocystis jirovecii pneumonia: development of a multiplex PCR-single-base-extension methodology. J. Clin. Microbiol. 49:1810-1815. http://dx.doi.org/10.1128/JCM. 02303-10.
29. Hauser PM, Blanc DS, Sudre P, Senggen Manoloff E, Nahimana A, Bille J, Weber R, Francioli P. 2001. Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. AIDS 15:461-466. http://dx.doi.org/10.1097/00002030-200103090-00004.
30. Maitte C, Leterrier M, Pape PL, Miegeville M, Morio F. 2013. Multilocus sequence typing of Pneumocystis jirovecii from clinical samples: how many and which loci should be used? J. Clin. Microbiol. 51:2843-2849. http://dx.doi.org/10.1128/JCM.01073-13.
31. Esteves F, Montes-Cano MA, de la Horra C, Costa MC, Calderón EJ, Antunes F, Matos O. 2008. Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. Clin. Microbiol. Infect. 14:356-362. http://dx.doi.org/10.1111/j.1469-0691.2007.01944.x.
32. Cissé OH, Pagni M, Hauser PM. 2012. De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavagefluid specimen from a patient. mBio 4:e00428-00412. http://dx.doi.org/10.1128/mBio.00428-12.
33. Nelson KE, Williams CM, Graham NM. 2004. Infectious disease epidemiology: theory and practice. Jones and Bartlett, Burlington, MA.
34. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J. 1996. A comprehensive genetic map of the human genome based on 5, 264 microsatellites. Nature 380:152-154. http://dx.doi.org/10.1038/380152a0.
35. Cortese JF, Caraballo A, Contreras CE, Plowe CV. 2002. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J. Infect. Dis. 186:999-1006. http://dx.doi.org/10.1086/342946.
36. Taylor SM, Antonia AL, Parobek CM, Juliano JJ, Janko M, Emch M, Alam MT, Udhayakumar V, Tshefu AK, Meshnick SR. 2013. Plasmodium falciparum sulfadoxine resistance is geographically and genetically clustered within the DR Congo. Sci. Rep. 3:1165. http://dx.doi.org/10.1038/srep01165.
37. Alvarez-Martínez MJ, Moreno A, Miró JM, Valls ME, Rivas PV, de Lazzari E, Sued O, Benito N, Domingo P, Ribera E, Santín M, Sirera G, Segura F, Vidal F, Rodríguez F, Riera M, Cordero ME, Arribas JR, Jiménez de Anta MT, Gatell JM, Wilson PE, Meshnick SR, Spanish Working Group PCP. 2008. Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. Diagn. Microbiol. Infect. Dis. 62:34-43. http://dx.doi.org/10.1016/j.diagmicrobio.2008. 04.016.
38. Yoon C, Subramanian A, Chi A, Crothers K, Meshnick SR, Taylor SM, Beard CB, Jarlsberg LG, Lawrence GG, Avery M, Swartzman A, Fong S, Roth B, Huang L, International HIV-Associated Opportunistic Pneumonias (IHOP) Study. 2013. Dihydropteroate synthase mutations in Pneumocystis pneumonia: impactofapplying different definitionsofprophylaxis, mortality endpoints and mutant in a single cohort. Med. Mycol. 51:568-575. http://dx.doi.org/10.3109/13693786.2013.770604.
39. Taylor SM, Meshnick SR, Worodria W, Andama A, Davis JL, Cattamanchi A, den Boon S, Yoo SD, Goodman CD, Huang L. 2012. Low prevalence of Pneumocystis jirovecii lung colonization in Ugandan HIV-infected patients hospitalized with non-Pneumocystis pneumonia. Diagn. Microbiol. Infect. Dis. 72:139-143. http://dx.doi.org/10.1016/j.diagmicrobio.2011.10.009.
40. Benson G. 1999. Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res. 27:573-580. http://dx.doi.org/10.1093/nar/27.2. 573.
41. Martins WS, Lucas D C S, Neves KF de, Bertioli S D J. 2009. WebSat-a web software for microsatellite marker development. Bioinformation 3:282-283. http://dx.doi.org/10.6026/97320630003282.
42. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
43. Cantarel BL, Korf I, Robb S M C, Parra G, Ross E, Moore B, Holt C, Sánchez Alvarado A, Yandell M. 2008. MAKER: an easy-to-use annotation pipeline designed for emerging model organism genomes. Genome Res. 18:188-196.
44. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
45. Brownstein MJ, Carpten JD, Smith JR. 1996. Modulation of nontemplated nucleotide addition by Taq DNA polymerase: primer modifications that facilitate genotyping. Biotechniques 20:1004-1006, 1008-1010.
46. Ford AF, Schall JJ. 2011. Relative clonal proportions over time in mixedgenotype infections of the lizard malaria parasite Plasmodium mexicanum. Int. J. Parasitol. 41:731-738. http://dx.doi.org/10.1016/j.ijpara.2011.01.010.
47. Van Den Eede P, Erhart A, der Auwera GV, Overmeir CV, Thang ND, Hung LX, Anne J, D'Alessandro U. 2010. High complexity of Plasmodium vivax infections in symptomatic patients from arural community in central Vietnam detected by microsatellite genotyping. Am. J. Trop. Med. Hyg. 82:223-227. http://dx.doi.org/10.4269/ajtmh.2010.09-0458.
48. Peakall R, Smouse PE. 2012. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics 28:2537-2539. http://dx.doi.org/10.1093/bioinformatics/bts460.
49. Excoffier L, Lischer H E L. 2010. Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows. Mol. Ecol. Resour. 10:564-567. http://dx.doi.org/10.1111/j.1755-0998.2010.02847.x.
50. Cavalli-Sforza LL, Edwards AW. 1967. Phylogenetic analysis. Models and estimation procedures. Am. J. Hum. Genet. 19:233-257.
51. Slatkin M. 1995. A measure of population subdivision based on microsatellite allele frequencies. Genetics 139:457-462.
52. Wright S. 1950. Genetical structure of populations. Nature 166:247-249. http://dx.doi.org/10.1038/166247a0.
53. Hardy O, Vekemans X. 2002. SPAGeDi: a versatile computer program to analyse spatial genetic structure at the individual or population levels. Mol. Ecol. Notes 2:618-620. http://dx.doi.org/10.1046/j.1471-8286.2002.00305.x.
54. Hamady M, Lozupone C, Knight R. 2010. Fast UniFrac: facilitating high-throughput phylogenetic analyses ofmicrobial communities including analysis ofpyrosequencing and PhyloChip data. ISMEJ. 4:17-27. http://dx.doi.org/10.1038/ ismej.2009.97.
55. Hunter PR, Gaston MA. 1988. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J. Clin. Microbiol. 26:2465-2466.
56. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
57. Paradis E, Claude J, Strimmer K. 2004. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20:289-290. http://dx.doi.org/10.1093/ bioinformatics/btg412.
58. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530. http://dx.doi.org/10.1128/JB.186.5.1518-1530.2004.
59. Hauser PM. 2004. The development of a typing method for an uncultivable microorganism: the example of Pneumocystis jirovecii. Infect. Genet. Evol. 4:199-203. http://dx.doi.org/10.1016/j.meegid.2004.01.011.
60. Esteves F, Gaspar J, Tavares A, Moser I, Antunes F, Mansinho K, Matos O. 2010. Population structure of Pneumocystis jirovecii isolated from immunodeficiency virus-positive patients. Infect. Genet. Evol. 10:192-199. http://dx.doi.org/10.1016/j.meegid.2009.12.007.
61. Pritchard JK, Stephens M, Donnelly P. 2000. Inference of population structure using multilocus genotype data. Genetics 155:945-959. http://www.genetics.org/content/155/2/945.
62. Cushion MT, Keely SP. 2013. Assembly and annotation of Pneumocystis jirovecii from the human lung microbiome. mBio 4:e00224. http://dx.doi.org/10. 1128/mBio.00224-13.
63. Holsinger KE, Weir BS. 2009. Genetics in geographically structured populations: defining, estimating and interpreting F (ST). Nat. Rev. Genet. 10:639-650. http://dx.doi.org/10.1038/nrg2611.
64. Hartl DL, Clark AG. 2006. Principles of population genetics, 4th ed. Sinauer Associates, Inc., Sunderland, MA.
65. Weisser M, Oostdijk EA, Willems R J L, Bonten M J M, Frei R, Elzi L, Halter J, Widmer AF, Top J. 2012. Dynamics of ampicillin-resistant Enterococcus faecium clones colonizing hospitalized patients: data from a prospective observational study. BMC Infect. Dis. 12:68. http://dx.doi.org/10.1186/1471- 2334-12-68.
66. Guerrero C, Bernasconi C, Burki D, Bodmer T, Telenti A. 1995. A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J. Clin. Microbiol. 33:304-307.
67. Martin I M C, Ison CA, Aanensen DM, Fenton KA, Spratt BG. 2004. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J. Infect. Dis. 189:1497-1505. http://dx.doi.org/10.1086/ 383047.
68. Marais BJ, Mlambo CK, Rastogi N, Zozio T, Duse AG, Victor TC, Marais E, Warren RM. 2013. Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa. J. Clin. Microbiol. 51:1818-1825. http://dx.doi.org/10.1128/JCM.00200-13.
69. Turner K M E, Hanage WP, Fraser C, Connor TR, Spratt BG. 2007. Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol. 7:30. http://dx.doi.org/10.1186/1471-2180-7-30.
70. Taylor JW, Geiser DM, Burt A, Koufopanou V. 1999. The evolutionary biology and population genetics underlying fungal strain typing. Clin. Microbiol. Rev. 12:126-146.
71. Wakefield AE, Fritscher CC, Malin AS, Gwanzura L, Hughes WT, Miller RF. 1994. Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences. J. Clin. Microbiol. 32:2959-2961.
72. Miller RF, Lindley AR, Malin AS, Ambrose HE, Wakefield AE. 2005. Isolates of Pneumocystis jirovecii from Harare show high genotypic similarity to isolates from London at the superoxide dismutase locus. Trans. R. Soc. Trop. Med. Hyg. 99:202-206. http://dx.doi.org/10.1016/j.trstmh.2004.09.005.
73. Tsolaki AG, Beckers P, Wakefield AE. 1998. Pre-AIDS era isolates of Pneumocystis carinii f. sp hominis: high genotype similarity with contemporary isolates. J. Clin. Microbiol. 36:90-93.
74. Kazanjian P, Armstrong W, Hossler PA, Burman W, Richardson J, Lee CH, Crane L, Katz J, Meshnick SR. 2000. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients. J. Infect. Dis. 182:551-557. http://dx.doi.org/10.1086/315719.
75. Meshnick SR. 1999. Drug-resistant Pneumocystis carinii. Lancet 354:1318-1319. http://dx.doi.org/10.1016/S0140-6736 (99) 00240-8.
76. Helweg-Larsen J, Benfield TL, Eugen-Olsen J, Lundgren JD, Lundgren B. 1999. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P carinii pneumonia. Lancet 354:1347-1351. http://dx.doi.org/10.1016/S0140-6736 (99) 03320-6.
77. Navin TR, Beard CB, Huang L, del Rio C, Lee S, Pieniazek NJ, Carter JL, Le T, Hightower A, Rimland D. 2001. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358:545-549. http://dx.doi.org/10.1016/ S0140-6736 (01) 05705-1.
78. Crothers K, Beard CB, Turner J, Groner G, Fox M, Morris A, Eiser S, Huang L. 2005. Severity and outcome of HIV-associated Pneumocystis pneumonia containing Pneumocystis jirovecii dihydropteroate synthase gene mutations. AIDS 19:801-805. http://dx.doi.org/10.1097/01.aids.0000168974.67090.70.
79. Hauser PM, Sudre P, Nahimana A, Francioli P, Study Group. 2001. Prophylaxis failure is associated with a specific Pneumocystis carinii genotype. Clin. Infect. Dis. 33:1080-1082. http://dx.doi.org/10.1086/322659.
80. Esteves F, Gaspar J, Marques T, Leite R, Antunes F, Mansinho K, Matos O. 2010. Identification of relevant single-nucleotide polymorphisms in Pneumocystis jirovecii: relationship with clinical data. Clin. Microbiol. Infect. 16:878-884. http://dx.doi.org/10.1111/j.1469-0691.2009.03030.x.
81. Beard CB, Carter JL, Keely SP, Huang L, Pieniazek NJ, Moura IN, Roberts JM, Hightower AW, Bens MS, Freeman AR, Lee S, Stringer JR, Duchin JS, del Rio C, Rimland D, Baughman RP, Levy DA, Dietz VJ, Simon P, Navin TR. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6:265-272. http://dx.doi.org/10.3201/eid0603.000306.
82. Gigliotti F, Wright TW. 2012. Pneumocystis: where does it live? PLoS Pathog. 8:e1003025. http://dx.doi.org/10.1371/journal.ppat.1003025.
83. Chabé M, Dei-Cas E, Creusy C, Fleurisse L, Respaldiza N, Camus D, Durand-Joly I. 2004. Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and RT-PCR data demonstrate active replication. Eur. J. Clin. Microbiol. Infect. Dis. 23:89-97. http://dx.doi.org/10.1007/s10096-003- 1092-2.
84. Totet A, Meliani L, Lacube P, Pautard JC, Raccurt C, Roux P, Nevez G. 2003. Immunocompetent infants as a human reservoir for Pneumocystis jirovecii: rapid screening by non-invasive sampling and real-time PCR at the mitochondria1 large subunit rRNA gene. J. Eukaryot. Microbiol. 50:668-669. http://dx.doi.org/10.1111/j.1550-7408.2003.tb00678.x.
85. Cushion MT. 2010. Are members of the fungal genus pneumocystis (a) commensals; (b) opportunists; (c) pathogens; or (d) allofthe above? PLoS Pathog. 6:e1001009. http://dx.doi.org/10.1371/journal.ppat.1001009.
86. Rivero L, de la Horra C, Montes-Cano MA, Rodriguez-Herrera A, Respaldiza N, Friaza V, Morilla R, Gutierrez S, Varela JM, Medrano FJ, Calderon EJ. 2008. Pneumocystis jirovecii transmission from immunocompetent carriers to infant. Emerg. Infect. Dis. 14:1116-1118. http://dx.doi.org/10.3201/eid1407.071431.
87. Dumoulin A, Mazars E, Seguy N, Gargallo-Viola D, Vargas S, Cailliez JC, Aliouat EM, Wakefield AE, Dei-Cas E. 2000. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur. J. Clin. Microbiol. Infect. Dis. 19:671-678. http://dx.doi.org/10.1007/ s100960000354.
88. Gigliotti F, Harmsen AG, Wright TW. 2003. Characterization of transmission of Pneumocystis carinii f.sp muris through immunocompetent BALB/c mice. Infect. Immun. 71:3852-3856. http://dx.doi.org/10.1128/IAI.71.7.3852-3856. 2003.
89. Ambrose HE, Ponce CA, Wakefield AE, Miller RF, Vargas SL. 2001. Distribution of Pneumocystis carinii f. sp hominis types in the lung of a child dying of Pneumocystis pneumonia. Clin. Infect. Dis. 33:e100-e102. http://dx.doi.org/10.1086/322690.
90. Dimonte S, Berrilli F, D'Orazi C, D'Alfonso R, Placco F, Bordi E, Perno CF, Di Cave D. 2013. Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy. Infect. Genet. Evol. 14:68-72. http://dx.doi.org/10.1016/j.meegid.2012. 11.012.